WHO WE ARE
We are a biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class therapies to treat ophthalmic disease. We continuously strive to advance breakthrough science and deliver therapies seeking to address the unmet needs of patients and eye care professionals.
Oyster Point is a people-focused organization with a strong culture of integrity, scientific excellence, and agility. We seek to deliver innovative and transformational therapies to positively impact the quality of patients’ lives.
Privacy & Cookies Policy